Adamantane derivatives

CAS: 1619-34-7

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacte...

CAS: 1193-65-3
The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacteria...

CAS: 25333-42-0The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial and...

CAS: 123536-14-1
The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacter...

CAS: 34583-34-1The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial and...

CAS: 119904-90-4

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibac...

Olainfarm offers various Quinuclidine derivatives

CAS: 665-66-7USP and CEP specifications

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, a...

CAS: 41100-52-1USP and In-house specifications

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health,...

CAS: 274901-16-5
The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial...

CAS:6530-09-2The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial and anti...

Olainfarm is one of the leading pharmaceutical manufacturers in chemical and pharmaceutical sector of the Baltic countries with 50 years of experience. Olainfarm exports solid FDFs, APIs and intermediates to more than 60 countries worldwide.

Olainfarm has a long-term strategy to expand portfolio and develop sustainable business in European countries and MENA region. Olainfarm develops, manufactures and distributes FDF products for treatment in Oncology, Neurology, Cardiology and Anti-diabetes therapeutical areas.

Olainfarm is one of the leading pharmaceutical manufacturers in chemical and pharmaceutical sector of the Baltic countries with 50 years of experience. Olainfarm exports solid FDFs, APIs and intermediates to more than 60 countries worldwide.

Olainfarm has a long-term strategy to expand portfolio and develop sustainable business in European countries and MENA region. Olainfarm develops, manufactures and distributes FDF products for treatment in Oncology, Neurology, Cardiology and Anti-diabetes therapeutical areas.